Please use this identifier to cite or link to this item: https://doi.org/10.1186/s12913-015-1230-4
DC FieldValue
dc.titleUsing meta-regression analyses in addition to conventional systematic review methods to examine the variation in cost-effectiveness results - A case study Utilization, expenditure, economics and financing systems
dc.contributor.authorBurgers, L.T
dc.contributor.authorVan De Wetering, F.T
dc.contributor.authorSeverens, J.L
dc.contributor.authorRedekop, W.K
dc.date.accessioned2020-10-27T10:47:55Z
dc.date.available2020-10-27T10:47:55Z
dc.date.issued2016
dc.identifier.citationBurgers, L.T, Van De Wetering, F.T, Severens, J.L, Redekop, W.K (2016). Using meta-regression analyses in addition to conventional systematic review methods to examine the variation in cost-effectiveness results - A case study Utilization, expenditure, economics and financing systems. BMC Health Services Research 16 (1) : 23. ScholarBank@NUS Repository. https://doi.org/10.1186/s12913-015-1230-4
dc.identifier.issn14726963
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/181396
dc.description.abstractBackground: Systematic reviews of cost-effectiveness analyses summarize results and describe study characteristics. Variability in the study results is often explained qualitatively or based on sensitivity analyses of individual studies. However, variability due to input parameters and study characteristics (e.g., funding or study quality) is often not statistically explained. As a case study, a systematic review on the cost-effectiveness of drug-eluting stents (DES) versus bare-metal stents (BMS) using meta-regression analyses is performed to explore the usefulness of such methods compared with conventional review methods. Methods: We attempted to identify and review all modelling studies published until January 2012 that compared costs and consequences of DES versus BMS. We extracted general study information (e.g., funding), modelling methods, values of input parameters, and quality of the model using the Philips et al. checklist. Associations between study characteristics and the incremental costs and effectiveness of individual analyses were explored using regression analyses corrected for study ID. Results: Sixteen eligible studies were identified, with a combined total of 508 analyses. The overall quality of the models was moderate (59 % ± 15 %). This study showed associations (e.g., type of lesion) that were expected (based on individual studies), however the meta-regression analyses revealed also unpredicted associations: e.g., model quality was negatively associated with repeat revascularizations avoided. Conclusions: Meta-regressions can be of added value, identifying significant associations that could not be identified using conventional review methods or by sensitivity analyses of individual studies. Furthermore, this study underlines the need to examine input parameters and perform a quality check of studies when interpreting the results. © 2016 Burgers et al.
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceUnpaywall 20201031
dc.subjectcost benefit analysis
dc.subjectdrug eluting stent
dc.subjecteconomics
dc.subjectregression analysis
dc.subjectstatistics and numerical data
dc.subjectCost-Benefit Analysis
dc.subjectDrug-Eluting Stents
dc.subjectRegression Analysis
dc.typeArticle
dc.contributor.departmentSAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
dc.description.doi10.1186/s12913-015-1230-4
dc.description.sourcetitleBMC Health Services Research
dc.description.volume16
dc.description.issue1
dc.description.page23
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1186_s12913-015-1230-4.pdf1.07 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons